HQY vs RMD: fair value comparison
HealthEquity, Inc. and ResMed Inc. · Updated 2026-09-06
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, HQY currently sits closer to the top of our discount ranking. RMD carries the stronger quality grade. HQY carries the stronger momentum grade.
| HQY | RMD | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $104.36 | $228.35 |
| 12-month range | $77.93–$104.36 | $186.44–$257.39 |
| Sector rank | #22 of 113 Healthcare | #24 of 113 Healthcare |
| Quality grade | C | A |
| Momentum grade | A | B |
| Leverage | Low | Low |
| Margin trend | — | Expanding |
| Revenue growth | — | Strong |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | — |
| DCF cross-check | — | Overvalued |
| 52-week position | The top quarter | The upper-middle quarter |
Full single-stock breakdowns: HQY fair value analysis · RMD fair value analysis